Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-16-065405

EVP, Chief Financial Officer acquired 10,413 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Burke Willaim P EVP, Chief Financial Officer 2016-10-25 Grant or award +10,413 $34.21 $356,229 10,413 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Burke Willaim P EVP, Chief Financial Officer 2016-10-25 Grant or award · Non-qualified Stock Option (Right to Buy) +44,926 $34.21 $1,536,918 44,926 D: show line 2 in the form
Burke Willaim P EVP, Chief Financial Officer 2016-10-25 Grant or award · Performance Shares +20,827 20,827 D: show line 3 in the form
Loading xslF345X03/form4.xml…